121 related articles for article (PubMed ID: 8911394)
1. Differential chromosome allelic imbalance in the progression of human prostate cancer.
Latil A; Fournier G; Cussenot O; Lidereau R
J Urol; 1996 Dec; 156(6):2079-83. PubMed ID: 8911394
[TBL] [Abstract][Full Text] [Related]
2. Allelic imbalance in hereditary and sporadic prostate cancer.
Verhage BA; van Houwelingen K; Ruijter TE; Kiemeney LA; Schalken JA
Prostate; 2003 Jan; 54(1):50-7. PubMed ID: 12481255
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer.
Jenkins R; Takahashi S; DeLacey K; Bergstralh E; Lieber M
Genes Chromosomes Cancer; 1998 Feb; 21(2):131-43. PubMed ID: 9491325
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer.
Latil A; Cussenot O; Fournier G; Baron JC; Lidereau R
Clin Cancer Res; 1995 Nov; 1(11):1385-9. PubMed ID: 9815935
[TBL] [Abstract][Full Text] [Related]
5. Allelic imbalance and microsatellite instability in prostatic adenocarcinoma.
Cunningham JM; Shan A; Wick MJ; McDonnell SK; Schaid DJ; Tester DJ; Qian J; Takahashi S; Jenkins RB; Bostwick DG; Thibodeau SN
Cancer Res; 1996 Oct; 56(19):4475-82. PubMed ID: 8813143
[TBL] [Abstract][Full Text] [Related]
6. Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression.
Takahashi S; Shan AL; Ritland SR; Delacey KA; Bostwick DG; Lieber MM; Thibodeau SN; Jenkins RB
Cancer Res; 1995 Sep; 55(18):4114-9. PubMed ID: 7664288
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer.
Kawana Y; Ichikawa T; Suzuki H; Ueda T; Komiya A; Ichikawa Y; Furuya Y; Akakura K; Igarashi T; Ito H
Prostate; 2002 Sep; 53(1):60-4. PubMed ID: 12210480
[TBL] [Abstract][Full Text] [Related]
8. Genetic alteration mapping on chromosome 7 in primary breast cancer.
Bièche I; Khodja A; Driouch K; Lidereau R
Clin Cancer Res; 1997 Jun; 3(6):1009-16. PubMed ID: 9815778
[TBL] [Abstract][Full Text] [Related]
9. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
[TBL] [Abstract][Full Text] [Related]
10. Primary adenocarcinomas of the lung in nonsmokers show a distinct pattern of allelic imbalance.
Wong MP; Lam WK; Wang E; Chiu SW; Lam CL; Chung LP
Cancer Res; 2002 Aug; 62(15):4464-8. PubMed ID: 12154056
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions.
Latil A; Cussenot O; Fournier G; Driouch K; Lidereau R
Cancer Res; 1997 Mar; 57(6):1058-62. PubMed ID: 9067271
[TBL] [Abstract][Full Text] [Related]
12. Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q.
Yin Z; Babaian RJ; Troncoso P; Strom SS; Spitz MR; Caudell JJ; Stein JD; Kagan J
Oncogene; 2001 Apr; 20(18):2273-80. PubMed ID: 11402322
[TBL] [Abstract][Full Text] [Related]
13. High frequency of mutator phenotype in human prostatic adenocarcinoma.
Gao X; Wu N; Grignon D; Zacharek A; Liu H; Salkowski A; Li G; Sakr W; Sarkar F; Porter AT
Oncogene; 1994 Oct; 9(10):2999-3003. PubMed ID: 8084604
[TBL] [Abstract][Full Text] [Related]
14. Genetic analysis of prostatic atypical adenomatous hyperplasia (adenosis).
Doll JA; Zhu X; Furman J; Kaleem Z; Torres C; Humphrey PA; Donis-Keller H
Am J Pathol; 1999 Sep; 155(3):967-71. PubMed ID: 10487854
[TBL] [Abstract][Full Text] [Related]
15. Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers.
Suzuki H; Komiya A; Emi M; Kuramochi H; Shiraishi T; Yatani R; Shimazaki J
Genes Chromosomes Cancer; 1996 Dec; 17(4):225-33. PubMed ID: 8946204
[TBL] [Abstract][Full Text] [Related]
16. Allelic imbalance at 13q14.2 approximately q14.3 in localized prostate cancer is associated with early biochemical relapse.
Brookman-Amissah N; Nariculam J; Freeman A; Willamson M; Kirby RS; Masters JR; Feneley MR
Cancer Genet Cytogenet; 2007 Dec; 179(2):118-26. PubMed ID: 18036398
[TBL] [Abstract][Full Text] [Related]
17. Allelic loss of chromosomes 16q and 10q in human prostate cancer.
Carter BS; Ewing CM; Ward WS; Treiger BF; Aalders TW; Schalken JA; Epstein JI; Isaacs WB
Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8751-5. PubMed ID: 1978938
[TBL] [Abstract][Full Text] [Related]
18. Genetic pathways and new progression markers for prostate cancer suggested by microsatellite allelotyping.
von Knobloch R; Konrad L; Barth PJ; Brandt H; Wille S; Heidenreich A; Moll R; Hofmann R
Clin Cancer Res; 2004 Feb; 10(3):1064-73. PubMed ID: 14871986
[TBL] [Abstract][Full Text] [Related]
19. Recessive genetic mechanisms in the oncogenesis of prostatic carcinoma.
Bergerheim US; Collins VP; Ekman P; Kunimi K
Scand J Urol Nephrol Suppl; 1991; 138():93-6. PubMed ID: 1686123
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetics of prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
Debruyne FM; Collins VP; van Dekken H; Jenkins RB; Klocker H; Schalken JA; Sesterhenn IA
Scand J Urol Nephrol Suppl; 1994; 162():65-71; discussion 115-27. PubMed ID: 7817161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
